Physician profile
Edward John Lind, II
NPI 1316956055
$2,397.02
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $408 · 2021: $177.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $557.35 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $370.78 | 2019-2020 | |
| Amgen INC. | $311.92 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.12 | 2019-2020 | |
| Welch Allyn | $177.38 | 2021 | |
| Amarin Pharma, INC. | $132.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $120.48 | 2019-2020 | |
| Astellas Pharma US INC | $120.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $112.81 | 2019 | |
| Antares Pharma, INC. | $42.93 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $36.28 | 2019 | |
| Mylan Specialty L.P. | $34.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.55 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $20.99 | 2019 | |
| Radius Health, INC. | $17.81 | 2019 | |
| Pfizer INC. | $15.93 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.92 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.37 | 2019 | |
| Lilly USA, LLC | $10.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.